EP2762119B1 - WUNDKAMMER FÜR GLIEDMAßE - Google Patents

WUNDKAMMER FÜR GLIEDMAßE Download PDF

Info

Publication number
EP2762119B1
EP2762119B1 EP14157342.8A EP14157342A EP2762119B1 EP 2762119 B1 EP2762119 B1 EP 2762119B1 EP 14157342 A EP14157342 A EP 14157342A EP 2762119 B1 EP2762119 B1 EP 2762119B1
Authority
EP
European Patent Office
Prior art keywords
wound dressing
chamber
treatment
tube
treatment space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14157342.8A
Other languages
English (en)
French (fr)
Other versions
EP2762119A1 (de
Inventor
Elof Eriksson
Robert W. Allison
Christian Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Tissue Technologies LLC
Original Assignee
Applied Tissue Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Tissue Technologies LLC filed Critical Applied Tissue Technologies LLC
Publication of EP2762119A1 publication Critical patent/EP2762119A1/de
Application granted granted Critical
Publication of EP2762119B1 publication Critical patent/EP2762119B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/10—Bandages or dressings; Absorbent pads specially adapted for fingers, hands, or arms; Finger-stalls; Nail-protectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/40—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00093—Wound bandages tubular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00157—Wound bandages for burns or skin transplants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/0017—Wound bandages possibility of applying fluid

Definitions

  • the invention relates generally to the field of wound treatment, and more particularly to a wound chamber for treating wounds on a limb of the body.
  • open wounds may be treated with moist or dry gauze.
  • such treatment may result in excessive pain, dehydration of the wound, loss of fluids and proteins, loss of heat or delayed healing.
  • burn wounds may be additionally treated with antibacterial creams and the like.
  • Open wounds appear to heal faster in an environment that is somewhere between moist and dry. Partial thickness wounds heal faster when covered with a polyethylene film than when exposed to air. Conventionally, dressings with some water permeability provide the optimal conditions for healing.
  • Wound chambers for protecting open wounds and providing environmental control of the treatment site have been developed.
  • exemplary wound chambers and methods for use are described in U.S. Patent No. 5,152,757 , entitled “System for Diagnosis and Treatment of Wounds,” by Elof Eriksson, and U.S. Patent Application No. 11/130,490 , entitled “Wound Chamber With Remote Access Portal,” by Eriksson et al.
  • WO 00/64394 also discloses an apparatus for stimulating healing of wounds with reduced pressure.
  • a wound chamber typically includes a chamber for enclosing a predetermined surface area about a wound on a patient.
  • the wound chamber is sealed to the skin immediately adjacent to the wound.
  • certain wounds on and around a limb may not be treatable by a wound chamber that is intended for use on relatively flat skin surfaces. Instead, it may be necessary to enclose all or a portion of a limb in a chamber in order to create a chamber environment around the wound.
  • the wound chamber may have a portal for introducing treatment fluid and treatment additives into the wound chamber and extracting wound fluid and/or air from the wound chamber. Such operations are typically performed using a syringe or similar delivery/extraction device.
  • the portal may be an injection portal made of a self-sealing material through which a hollow steel needle can be passed.
  • a steel needle in close proximity to the patient creates a risk of injury to the patient and also to the health care provider. An additional risk of the needle damaging the wound chamber is also present.
  • the wound chamber itself may be covered by a secondary dressing or covering, such as gauze or an elastic bandage. In such circumstances, a portal located directly on the chamber would be covered by the secondary dressing and would be inaccessible.
  • the present invention is directed to providing a chamber to treat wounds on limbs, and to overcoming, or at least reducing the effects of, one or more of the problems set forth above.
  • a wound dressing includes a chamber defining a treatment space and at least one opening communicating with the treatment space.
  • a plurality of channels are defined on an inner wall of the chamber.
  • a tube extends through the chamber and into the treatment space and defines a plurality of openings in a portion of the tube extending into the treatment space.
  • a tube extends through the chamber and into the treatment space and comprises a plurality of branches extending to different regions of the treatment space.
  • the limb dressing 10 includes a chamber 12 defining a treatment space 14.
  • a limb 16 with a wound 18 is shown within the treatment space 14.
  • the limb dressing 10 includes an opening 20 that communicates with the treatment space 14 and may be sealed about the limb 16 of a patient so that the wound 18 to be treated is enclosed within the treatment space 14.
  • FIGS 2-5 various techniques may be used to secure the limb dressing 10 to the limb 16.
  • the opening 20 has no integrated system for sealing.
  • Adhesive tape 25 may be applied by a user employing the limb dressing 10.
  • an adhesive material 24 is provided on the inside of the chamber wall near the opening 20.
  • Figure 4 shows a cuff 26 and cooperating drawstring 27.
  • Figure 5 shows connecting straps 28.
  • a seam 29 may be opened to facilitate the installation of the chamber 12 around the limb 16.
  • the seam 29 may be unsealed and resealed by numerous methods known to those of ordinary skill in the art, such as with an adhesive tape.
  • the seam 29 allows the limb dressing 10 to be applied in a manner that reduces the likelihood of contact between the chamber 12 and the wound 18 as the limb 16 is passed through the opening 20.
  • tabs 30 may be used to reduce the cross-sectional area of the chamber 12 to gather the chamber 12 around the limb after the chamber 12 has been installed.
  • the tabs 30 may be used to gather any loose material around the limb after the chamber has been installed.
  • the tabs 30 may be constructed of Velcro® or other self-sticking material.
  • the tabs 30 may also be simple drawstrings that are tied to one another. In general, the tabs 30 can be joined to one another to gather any loose material of the chamber 12, particularly in the case of a patient with a small limb 16.
  • a tube 31 is attached to the chamber 12 and communicates with the treatment space 14.
  • the tube 31 may be permanently fixed to the chamber 12, or a fitting 39 may be provided to allow removal of the tube 31.
  • the tube 31 is constructed so that it will maintain its shape, and will not collapse.
  • a distal end of the tube 31 terminates in a portal 34.
  • the portal 34 may be a female Luer fitting.
  • portal and fitting may be used interchangeably, depending on the particular implementation.
  • a fitting generally refers to a device that mates with a complementary, interfacing device, while a portal may relate to a device into which something is inserted, such as a needle.
  • the tube 31 is sealed to the chamber 12 in such a manner as to prevent the escape of liquid or air from the treatment space 14.
  • the juncture of the tube 31 and the chamber 12 may be reinforced with a flange 32.
  • only one tube 31 and portal 34 are illustrated, the invention is not so limited, and multiple tubes 31 and associated portals 34 may be provided for accessing the treatment space 14.
  • One tube 31 and portal 34 may be used as an inlet for providing treatment substances to the treatment space 14, while another tube 31 and portal 34 may be used as an outlet for removing substances from the treatment space 14.
  • Such an inlet and outlet arrangement may be useful for administering a continuous treatment stream.
  • the tube 31 may terminate at a wall of the chamber 12, or it may extend through the wall a distance and terminate within the treatment space 14 as shown in Figures 8-10 .
  • the composition of the chamber 12 maybe strengthened in area 33 as shown in Figure 8 by increasing the thickness of the walls of chamber 12 to provide further protection for the portion 38 of the tube 31 within treatment space 14.
  • the portion 38 of the tube 31 within the treatment space 14 may be perforated with one or more holes 35 to facilitate the flow of liquid or air through the tube 31.
  • the tube 31 may extend further into treatment space 14 in branches 37 as shown in Figures 9 and 10 .
  • walls 40 of chamber 12 may be configured on the interior side with ridges 41 that define channels, as in Figure 11 , or with grooves 42, as in Figure 12 , or by a combination of both.
  • the channels or grooves admit the flow of liquid or air.
  • the movement of liquid and air throughout the treatment space 14 and in and out of the chamber 12 is facilitated.
  • the channels or grooves maybe disposed as a pattern of short nubs or depressions 43 as seen in Figure 13 , as an irregular grid 44 as shown in Figure 14 , as a series of branches 45 as shown in Figure 15 , as a series of narrow bands 46 as shown in Figure 16 , or in other configurations achieving a similar result.
  • a delivery/extraction device 51 such as a syringe, may be engaged with the portal 34 to allow delivery of treatment fluid and/or treatment additives to the treatment space 14 or removal of liquid or gases from the treatment space 14.
  • the delivery/extraction device 51 may include a fitting 53, such as a male Luer fitting, complementary to a female Luer fitting used as the portal 34. In the case of complementary female and male Luer fittings, the rotation of the male fitting 53 on the delivery/extraction device 51 opens a valve in the female portal 34 extending from the tube 31.
  • the delivery/extraction device 51 may include devices other than the syringe illustrated.
  • the delivery/extraction device 51 may include a rigid or flexible container for holding one or more liquid or powdered treatment substances that may be delivered to the treatment space 14.
  • fitting 34 may be constructed of a self-sealing material to accommodate a syringe having a hollow steel needle that is inserted through the self-sealing material to allow injection of fluids and/or withdrawal of wound fluid or air from the treatment space 14.
  • Figure 18 shows a fitting 54 containing an exhaust valve 55.
  • the delivery/extraction device 51 can be operated to exhaust air from the chamber treatment space 14.
  • the valve 55 can be set to admit the flow of liquid from the delivery/extraction device 51 into the delivery tube 31.
  • Other valves with various automatic, semi-automatic, and manual operations may be used to facilitate the extraction or introduction of air and liquid.
  • the length of the tube 31 may vary with the particular implementation. In an application where the tube 31 is provided to increase the distance between the delivery/extraction device 51 to protect the patient and/or chamber 12 from a needle, the tube 31 should be at least longer than the needle. In cases where the limb dressing 10 is intended to be covered with a secondary dressing, the tube 31 may be still longer. For example, the tube 31 may be between one inch and twenty-four inches in length.
  • the tube 31 is generally flexible and may be foldable against itself depending on the specific implementation.
  • the tube 31 of Figure 1 is a collapsible tube 61 formed of a flexible, collapsible material that normally lies flat.
  • the delivery/extraction device 51 may be a syringe with a flexible tip 63 that is inserted into the collapsible tube 61.
  • the flexible tip 63 may be inserted throughout the entire length of the collapsible tube 61 such that it exits the collapsible tube 61 and extends directly into the treatment space 14. In some embodiments, e.g., where fluids are being added, the flexible tip 63 may be shorter than the collapsible tube 61.
  • the collapsible tube 61 expands as necessary to allow the insertion of the flexible tip 63 and/or treatment fluids. When the flexible tip 63 is withdrawn, the collapsible tube 61 collapses and forms a watertight and airtight seal with respect to the treatment space 14.
  • the collapsible tube 61 may have a flared end 62 where it interfaces with the chamber 12, i.e., either terminating at the chamber 12 or extending into the chamber 12.
  • the flexible tip 63 may be positioned within the flared end 62, yet not within the treatment space 14 to allow removal of fluids or air from the treatment space 14.
  • the tube 31 may be equipped with a portal 34 that is a fitting, such as female Luer fitting, as well as an auxiliary portal 66, which may be made of self-sealing material for example, located on a branch tube 65.
  • a portal 34 that is a fitting, such as female Luer fitting
  • an auxiliary portal 66 which may be made of self-sealing material for example, located on a branch tube 65.
  • the tube 31 allows the portal 34 to be located a distance away from the limb 16, the wound 18, and the chamber 12. Hence, if treatment fluids are be introduced into the treatment space 14 using a needle, the likelihood of inadvertently contacting the patient or health care provider or breaching the chamber 12 is reduced. Also, if the limb dressing 10 is covered by a secondary dressing (not shown), the wound 18 may still be treated through the tube 31 without requiring removal of the secondary dressing.
  • the limb dressing 10 described above has numerous applications.
  • the tube 31 may be used to introduce a wide variety of treatment fluids and/or additives.
  • the limb dressing 10 allows monitoring of the wound 18, which is useful in enhancing the healing process.
  • the chamber 12 allows visual monitoring of the wound 18 itself as well as the monitoring of fluid within the treatment space. This monitoring provides feedback to assist in the precise control of treatment variables and facilitates research.
  • Fluid extracted from the system can be analyzed for factors that indicate wound healing status and also for the presence of deleterious factors such as microorganisms, low oxygen, high carbon dioxide and adverse pH.
  • the fluid may be tested for the number and type of bacteria and other microorganisms per cc of fluid, the number and type of cells, the amount and type of proteins, and other factors.
  • Clinical diagnosis of the wound physiology and the patient may also be conducted. Upon diagnosis, further treatment of the wound 18 may be commenced by introducing treatment additives and controlling treatment variables. Depending on the type of wound, the extracted fluid can be tested, e.g., for: (a) the presence of microorganisms, (b) cells, (c) amount and type of protein, (d) chemicals, (e) oxygen, (f) carbon dioxide levels, and/or (g) pH. This data may be recorded and used for wound diagnosis. Once diagnosis is complete, fluid treatment intervention may be adjusted accordingly.
  • Additional growth factors that are produced by the wound 18 may also be measured when extracted fluid is analyzed. Additional factors that may be tested for are the presence and the amounts of various inflammatory mediators and various antigens. The presence of antigens could serve an important diagnostic purpose and may be tested with specific antibodies that would be delivered through the wound chamber. This information is useful in deciding what to replace and how to treat, and would indicate improvement of the wound 18.
  • the limb dressing 10 establishes an environment that allows the positive factors produced by the body to be present.
  • treatment materials includes anesthetics, antibiotics, chemotherapeutics, growth factors, cell culture media, cells, oxygen, buffering agents, enzymes, and immune modulators.
  • the cells added may include cells that have been genetically modified prior to transplantation in the wound 18 or may include other gene therapy additives such as DNA, genes, genetic material, genetic vectors, etc.
  • the limb dressing 10 also allows control of the treatment environment within the treatment space 14.
  • An exemplary, but not exhaustive, list of treatment variables includes temperature, colloid osmotic pressure, pH, ion concentration, glucose concentration, amino acid content, fat concentration, oxygen concentration, and carbon dioxide concentration.
  • treatment techniques By controlling treatment variables and by adding selected treatment additives, a variety of treatment techniques may be implemented. Those of ordinary skill in the art, in light of this disclosure, may identify numerous such treatment techniques, and the application of the present invention is not limited to any particular treatments.
  • a non-limiting sample of treatments that may be implemented in accordance with the present invention include cell treatment techniques, such as application of stem cells, gene therapy drugs, or cellular matrix gel suspension, infection treatment techniques, such as antibacterial or bacteriostatic treatments, or general treatment techniques, such as negative pressure therapy.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Claims (15)

  1. Wundverband, umfassend:
    eine Kammer (12), die einen Behandlungsraum (14) definiert und mindestens eine Öffnung (20) hat, deren Größe die Aufnahme eines verwundeten Körperglieds (16) eines Patienten ermöglicht;
    eine Leitung (31) mit einem ersten Ende, das an der Kammer (12) angeschlossen ist, und einem zweiten Ende, das ein Portal (34) definiert, wobei die Leitung (31) mit dem Behandlungsraum (14) kommuniziert; and
    eine Vielzahl von Kanälen, die an einer Innenwand der Kammer (12) definiert sind.
  2. Wundverband nach Anspruch 1, wobei das Portal (34) einen Anschluss (54) umfasst, der aus einem selbstabdichtenden Material gefertigt ist, um eine Injektionsspritze mit einer Nadel aufzunehmen.
  3. Wundverband nach Anspruch 1 oder 2, wobei die Leitung (31) faltbar ist.
  4. Wundverband nach einem der vorherigen Ansprüche, wobei sich die Leitung (31) in den Behandlungsraum (14) erstreckt.
  5. Wundverband nach einem der vorherigen Ansprüche, wobei die Leitung (31) Löcher (35) oder eine Vielzahl von Zweigleitungen (37) umfasst.
  6. Wundverband nach einem der vorherigen Ansprüche, ferner umfassend eine Verabreichungs-/Absaugvorrichtung (51), die für den Eingriff mit dem Portal (34) angepasst ist.
  7. Wundverband nach Anspruch 6, wobei die Verabreichungs-/Absaugvorrichtung (51) so konfiguriert ist, dass sie die Verabreichung von Behandlungsflüssigkeit und/oder Behandlungsadditiven in den Behandlungsraum (14) oder Entfernung von Flüssigkeit oder Gasen aus dem Behandlungsraum (14) ermöglicht.
  8. Wundverband nach Anspruch 6 oder 7, wobei die Verabreichungs-/Absaugvorrichtung (51) eine flexible Spitze (63) umfasst.
  9. Wundverband nach einem der vorherigen Ansprüche, ferner umfassend einen Anschluss (54), der ein automatisches Ventil, ein halbautomatisches Ventil, ein Handventil oder ein Auslassventil (55) enthält, um den Abzug oder das Einleiten von Luft und Flüssigkeit aus dem bzw. in den Behandlungsraum ermöglicht.
  10. Wundverband nach einem der vorherigen Ansprüche, der konfiguriert ist, um die Wundüberwachung oder Überwachung von Flüssigkeit im Behandlungsraum zu ermöglichen, um die Kontrolle von Behandlungsvariablen, einschließlich Temperatur, osmotischer Druck von Kolloid, pH-Wert, Ionenkonzentration, Glukosekonzentration, Aminosäuregehalt, Fettkonzentration, Sauerstoffkonzentration und Kohlendioxidkonzentration zu unterstützen.
  11. Wundverband nach einem der vorherigen Ansprüche, ferner umfassend ein Behandlungsmaterial, einschließlich Anästhetikum, Antibiotika, Chemotherapeutikum, Wachstumsfaktoren, Zellkulturmedium, Zellen, Sauerstoff, Puffermittel, Enzyme oder Immunmodulatoren.
  12. Wundverband nach einem der vorherigen Ansprüche, wobei die Leitung ein Hilfsportal (66) umfasst.
  13. Wundverband nach einem der vorherigen Ansprüche, wobei die Kanäle in mindestens einem von einem linear unterbrochenen Muster, einem Rastermuster, einem Muster aus einer Reihe von Abzweigungen und einem Bandmuster angeordnet sind.
  14. Wundverband nach einem der vorherigen Ansprüche, wobei die Kanäle mindestens eines von Graten (41) und Rillen (42) umfassen, die an der Innenwand der Kammer (12) definiert sind.
  15. Wundverband nach einem der vorherigen Ansprüche, ferner umfassend eine Lasche (30), die konfiguriert ist, um eine Querschnittsfläche der Kammer (12) zu reduzieren.
EP14157342.8A 2005-06-29 2006-06-29 WUNDKAMMER FÜR GLIEDMAßE Active EP2762119B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69484905P 2005-06-29 2005-06-29
EP06785857.1A EP1906903B1 (de) 2005-06-29 2006-06-29 Wundkammer für eine gliedmasse

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP06785857.1A Division EP1906903B1 (de) 2005-06-29 2006-06-29 Wundkammer für eine gliedmasse
EP06785857.1A Division-Into EP1906903B1 (de) 2005-06-29 2006-06-29 Wundkammer für eine gliedmasse

Publications (2)

Publication Number Publication Date
EP2762119A1 EP2762119A1 (de) 2014-08-06
EP2762119B1 true EP2762119B1 (de) 2016-08-17

Family

ID=37596048

Family Applications (2)

Application Number Title Priority Date Filing Date
EP06785857.1A Active EP1906903B1 (de) 2005-06-29 2006-06-29 Wundkammer für eine gliedmasse
EP14157342.8A Active EP2762119B1 (de) 2005-06-29 2006-06-29 WUNDKAMMER FÜR GLIEDMAßE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP06785857.1A Active EP1906903B1 (de) 2005-06-29 2006-06-29 Wundkammer für eine gliedmasse

Country Status (9)

Country Link
US (1) US8298197B2 (de)
EP (2) EP1906903B1 (de)
JP (1) JP5555828B2 (de)
CN (1) CN101257877B (de)
AU (1) AU2006263650B2 (de)
CA (1) CA2656518C (de)
ES (2) ES2600470T3 (de)
HK (1) HK1201710A1 (de)
WO (1) WO2007002835A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024142121A1 (en) * 2022-12-28 2024-07-04 Oxyvix S.R.L. Improved district normobaric oxygen therapy apparatus

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US11511094B2 (en) 2006-11-21 2022-11-29 Mark R. Moore Apparatus and method for deploying a surgical preparation
US10470842B2 (en) 2006-11-21 2019-11-12 Mark R. Moore Apparatus and method for deploying a surgical preparation
US8758310B2 (en) * 2006-11-21 2014-06-24 Mark R. Moore Apparatus and method for deploying a surgical preparation
US10188842B2 (en) 2006-11-21 2019-01-29 Mark R. Moore Apparatus and method for deploying a surgical preparation
US9409005B2 (en) * 2006-11-21 2016-08-09 Mark R. Moore Apparatus and method for deploying a surgical preparation
AU2008262140B2 (en) * 2007-05-24 2014-04-24 Applied Tissue Technologies Llc Wound treatment device employing negative pressure
CA2705898C (en) 2007-11-21 2020-08-25 Smith & Nephew Plc Wound dressing
WO2009066105A1 (en) 2007-11-21 2009-05-28 Smith & Nephew Plc Wound dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
GB2455962A (en) 2007-12-24 2009-07-01 Ethicon Inc Reinforced adhesive backing sheet, for plaster
KR101608548B1 (ko) 2008-03-05 2016-04-01 케이씨아이 라이센싱 인코포레이티드 조직 부위에 감압을 가하고，조직 부위로부터 유체를 수집 및 저장하는 드레싱 및 방법
US9033942B2 (en) 2008-03-07 2015-05-19 Smith & Nephew, Inc. Wound dressing port and associated wound dressing
US8298200B2 (en) 2009-06-01 2012-10-30 Tyco Healthcare Group Lp System for providing continual drainage in negative pressure wound therapy
US20100324516A1 (en) 2009-06-18 2010-12-23 Tyco Healthcare Group Lp Apparatus for Vacuum Bridging and/or Exudate Collection
EP3520830B1 (de) 2009-12-22 2023-10-18 Smith & Nephew, Inc. Vorrichtungen für unterdruckwundtherapie
US8814842B2 (en) 2010-03-16 2014-08-26 Kci Licensing, Inc. Delivery-and-fluid-storage bridges for use with reduced-pressure systems
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
USRE48117E1 (en) 2010-05-07 2020-07-28 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
RU2582866C2 (ru) 2010-12-22 2016-04-27 Смит Энд Нефью, Инк. Устройство и способ лечения ран отрицательным давлением
USD714433S1 (en) 2010-12-22 2014-09-30 Smith & Nephew, Inc. Suction adapter
GB2488749A (en) 2011-01-31 2012-09-12 Systagenix Wound Man Ip Co Bv Laminated silicone coated wound dressing
GB201106491D0 (en) 2011-04-15 2011-06-01 Systagenix Wound Man Ip Co Bv Patterened silicone coating
US10940047B2 (en) 2011-12-16 2021-03-09 Kci Licensing, Inc. Sealing systems and methods employing a hybrid switchable drape
EP2802304B1 (de) 2011-12-16 2015-12-09 KCI Licensing, Inc. Ablösbare medizinische abdecktücher
EP2636417B1 (de) 2012-03-05 2017-04-26 Lohmann & Rauscher GmbH Wundversorgungsanordnung und Abdeckeinrichtung dafür
SG11201503860RA (en) 2012-11-16 2015-06-29 Kci Licensing Inc Medical drape with pattern adhesive layers and method of manufacturing same
GB201222770D0 (en) 2012-12-18 2013-01-30 Systagenix Wound Man Ip Co Bv Wound dressing with adhesive margin
US9283118B2 (en) 2013-03-14 2016-03-15 Kci Licensing, Inc. Absorbent dressing with hybrid drape
EP3578209B1 (de) 2013-08-26 2023-12-20 3M Innovative Properties Company Verbandschnittstelle mit feuchtigkeitsregelungsfunktion und dichtungsfunktion
CN104511086A (zh) * 2013-10-08 2015-04-15 王宗鼎 一种无接触封闭负压引流装置以及使用方法
US10946124B2 (en) 2013-10-28 2021-03-16 Kci Licensing, Inc. Hybrid sealing tape
US9956120B2 (en) 2013-10-30 2018-05-01 Kci Licensing, Inc. Dressing with sealing and retention interface
CN110652396B (zh) 2013-10-30 2021-11-23 3M创新知识产权公司 具有不同大小的穿孔的敷件
WO2015065615A1 (en) 2013-10-30 2015-05-07 Kci Licensing, Inc. Absorbent conduit and system
US10398814B2 (en) 2013-10-30 2019-09-03 Kci Licensing, Inc. Condensate absorbing and dissipating system
WO2015130471A1 (en) 2014-02-28 2015-09-03 Kci Licensing, Inc. Hybrid drape having a gel-coated perforated mesh
US11026844B2 (en) 2014-03-03 2021-06-08 Kci Licensing, Inc. Low profile flexible pressure transmission conduit
EP3137029B1 (de) 2014-05-02 2020-09-09 KCI Licensing, Inc. Flüssigkeitsaufbewahrungsvorrichtungen, systeme und verfahren
US10561534B2 (en) 2014-06-05 2020-02-18 Kci Licensing, Inc. Dressing with fluid acquisition and distribution characteristics
US10398604B2 (en) 2014-12-17 2019-09-03 Kci Licensing, Inc. Dressing with offloading capability
EP3294245B1 (de) 2015-05-08 2019-09-04 KCI Licensing, Inc. Verband für geringe akuität mit integrierter pumpe
EP3117806B1 (de) * 2015-07-16 2020-06-10 Lohmann & Rauscher GmbH Wundversorgungsanordnung
EP3741335B1 (de) 2015-09-01 2023-05-24 KCI Licensing, Inc. Verband mit erhöhter appositionskraft
EP3892310A1 (de) 2015-09-17 2021-10-13 3M Innovative Properties Co. Hybride silikon- und acrylklebeabdeckung zur verwendung bei der wundbehandlung
CN106137648B (zh) * 2016-06-30 2019-06-04 山东大学齐鲁医院 嵌合式移动无菌换药车
IL264163B2 (en) 2016-07-15 2024-02-01 Surgibox Inc An ultra-portable system for intraoperative isolation and regulation of surgical site environments
GB201811449D0 (en) 2018-07-12 2018-08-29 Smith & Nephew Apparatuses and methods for negative pressure wound therapy
US11696962B2 (en) 2019-10-16 2023-07-11 Mark R. Moore Apparatus and method for deploying a preoperative skin disinfection device with integrated drape
GB202000574D0 (en) 2020-01-15 2020-02-26 Smith & Nephew Fluidic connectors for negative pressure wound therapy
US11844918B2 (en) * 2021-04-25 2023-12-19 Tri.O Medical Device Ltd Apparatus for use with a pressure-regulating device

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5122888U (de) * 1974-08-09 1976-02-19
JPS5122888A (de) 1974-08-20 1976-02-23
US4003371A (en) * 1975-02-13 1977-01-18 Fischer Boguslav Low pressure hyperbaric chamber
US4353359A (en) * 1979-07-16 1982-10-12 Milbauer Nathaniel A Portable jacket for treatment and protection of injured body members
US4772259A (en) * 1987-06-12 1988-09-20 Ballard Medical Products Hyperbaric oxygenation apparatus and methods
US5152757A (en) 1989-12-14 1992-10-06 Brigham And Women's Hospital System for diagnosis and treatment of wounds
US5312385A (en) * 1991-10-09 1994-05-17 University Of Pittsburgh Device for protected pulse irrigation
CN2114442U (zh) * 1991-10-18 1992-09-02 张大同 一种敷料装置
US5807290A (en) 1992-05-29 1998-09-15 South Glamorgan Health Authority Inflatable supports
GB9307312D0 (en) * 1993-04-07 1993-06-02 United Surgical Services Ltd Surgical wound dressings
US5447504A (en) * 1993-05-03 1995-09-05 Baker; Gregg R. Misting apparatus for the treatment of injured areas and method therefor
US5437602A (en) * 1993-08-13 1995-08-01 Atm Wound Management, Inc. Isolator bag for therapeutic treatments of human limbs
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5527265A (en) * 1994-08-16 1996-06-18 Mckeel; William H. Orthopedic airflow cast pad and method
WO1996034638A1 (en) 1995-05-02 1996-11-07 Medela, Inc. Foot-powered breastmilk pump with removable piston pump
US5605534A (en) * 1995-12-26 1997-02-25 Hutchison; Jeffrey W. Shower guard for IV site
US5592953A (en) * 1996-04-02 1997-01-14 Delao; Wenda K. Tubular sleeve with elasticized sealing means
US5848998A (en) * 1996-07-11 1998-12-15 Marasco, Jr.; Patrick V. Tissue debriding apparatus
US6053882A (en) * 1996-08-15 2000-04-25 Johansen; Jan S. Cast ventilation sleeve
US6290685B1 (en) 1998-06-18 2001-09-18 3M Innovative Properties Company Microchanneled active fluid transport devices
GB9909301D0 (en) * 1999-04-22 1999-06-16 Kci Medical Ltd Wound treatment apparatus employing reduced pressure
GB9926538D0 (en) * 1999-11-09 2000-01-12 Kci Medical Ltd Multi-lumen connector
GB0115054D0 (en) * 2001-06-20 2001-08-15 Recuperatio Ltd Fluid transfer device
US7520872B2 (en) * 2002-09-13 2009-04-21 Neogen Technologies, Inc. Closed wound drainage system
GB0424562D0 (en) * 2004-11-05 2004-12-08 Huntleigh Technology Plc Compression device
US7540283B2 (en) * 2005-02-24 2009-06-02 Aoti, Inc. Hyperbaric oxygen devices and delivery methods
US20060293630A1 (en) * 2005-06-22 2006-12-28 Misonix Incorporated Fluid containment apparatus for surgery and method of use
MX2009003870A (es) 2006-10-13 2009-04-30 Kci Licensing Inc Sistema de entrega de presion reducida que tiene una bomba activada manualmente para proporcionar tratamiento para heridas de poca gravedad.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024142121A1 (en) * 2022-12-28 2024-07-04 Oxyvix S.R.L. Improved district normobaric oxygen therapy apparatus

Also Published As

Publication number Publication date
ES2479990T3 (es) 2014-07-25
JP2009500107A (ja) 2009-01-08
CA2656518C (en) 2015-11-17
US20090124987A1 (en) 2009-05-14
WO2007002835A3 (en) 2007-03-29
AU2006263650A1 (en) 2007-01-04
AU2006263650A8 (en) 2008-04-03
EP2762119A1 (de) 2014-08-06
WO2007002835A2 (en) 2007-01-04
CN101257877B (zh) 2013-07-17
AU2006263650B2 (en) 2012-03-15
CN101257877A (zh) 2008-09-03
EP1906903A2 (de) 2008-04-09
JP5555828B2 (ja) 2014-07-23
ES2600470T3 (es) 2017-02-09
CA2656518A1 (en) 2007-01-04
US8298197B2 (en) 2012-10-30
EP1906903B1 (de) 2014-04-16
HK1201710A1 (en) 2015-09-11
EP1906903A4 (de) 2013-03-27

Similar Documents

Publication Publication Date Title
EP2762119B1 (de) WUNDKAMMER FÜR GLIEDMAßE
US20050267424A1 (en) Wound chamber with remote access portal
US9180230B2 (en) System and method for delivering reduced pressure to subcutaneous tissue
US6979324B2 (en) Closed wound drainage system
US20060116620A1 (en) Wound alternative treatment system
JP2013150816A (ja) 減圧を使用する創傷部治療装置
WO2017195181A1 (en) Wound therapy
US20020182246A1 (en) Device for treating and promoting healing of damaged body tissue
CN205411763U (zh) 伤口造瘘引流袋
US20070060899A1 (en) Device for treating and promoting healing of damaged body tissue
US20040185089A1 (en) Device for treating and promoting healing of damaged body tissue
CN105435317A (zh) 伤口造瘘引流袋

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140228

AC Divisional application: reference to earlier application

Ref document number: 1906903

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

R17P Request for examination filed (corrected)

Effective date: 20150206

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1201710

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20151126

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160509

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAR Information related to intention to grant a patent recorded

Free format text: ORIGINAL CODE: EPIDOSNIGR71

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

INTG Intention to grant announced

Effective date: 20160706

AC Divisional application: reference to earlier application

Ref document number: 1906903

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BAKER, CHRISTIAN

Inventor name: ERIKSSON, ELOF

Inventor name: ALLISON, ROBERT W.

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 820342

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160915

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006050021

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20160817

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 820342

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2600470

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20170209

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161118

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161219

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006050021

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161117

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20170518

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1201710

Country of ref document: HK

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170630

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170629

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170630

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170629

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20060629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161217

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230517

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230707

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240620

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240618

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240621

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240627

Year of fee payment: 19